Halozyme Therapeutics, Inc. · NASDAQ:HALO

BlackRock, Inc. reported a 10.20% stake in Halozyme Therapeutics, Inc. (Schedule 13G/A)

Event Jun 30, 2025 · Filed Jul 17, 2025

BlackRock, Inc. reported a 10.20% stake in Halozyme Therapeutics, Inc., 12,612,300 shares, as a passive investor on Jun 30, 2025. Filed Jul 17, 2025 (Schedule 13G/A).

Stake
10.20%
Shares
12,612,300
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
BlackRock, Inc.10.20%12,612,300

Source

View original at SEC

Related